No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs369531944 |
chr5:115893913-115893914 |
Enhancers Weak transcription Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs559942934 |
chr5:115893998-115893999 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs190116544 |
chr5:115894008-115894009 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs570459580 |
chr5:115894019-115894020 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs530318844 |
chr5:115894046-115894047 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs539607101 |
chr5:115894082-115894083 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs200809850 |
chr5:115894149-115894150 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs375971715 |
chr5:115894150-115894151 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs369006905 |
chr5:115894151-115894152 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs12658703 |
chr5:115894220-115894221 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs569922940 |
chr5:115894221-115894222 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs566749337 |
chr5:115894271-115894272 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs1700486 |
chr5:115894438-115894439 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs181708865 |
chr5:115894451-115894452 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs377100610 |
chr5:115894454-115894455 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs369614232 |
chr5:115894455-115894456 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs372734789 |
chr5:115894456-115894457 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs199824220 |
chr5:115894457-115894458 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs578155629 |
chr5:115894493-115894494 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs545993283 |
chr5:115894539-115894540 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs254210 |
chr5:115894566-115894567 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
22 |
rs254209 |
chr5:115894579-115894580 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs542100743 |
chr5:115894588-115894589 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs147896492 |
chr5:115894595-115894596 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs530481002 |
chr5:115894652-115894653 |
Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs550318169 |
chr5:115894663-115894664 |
Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs570181915 |
chr5:115894700-115894701 |
Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs141563898 |
chr5:115894702-115894703 |
Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|